Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Read G. F., et al.The use of salivary progesterone assays in the assessment of ovarian function in postmenarcheal girls. J. Endocrinol., 1984; 102:265–268.

Reddy R., et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science, 2008; 319 (1):611–613.

Rees M. C. P. Human Menstruation and Eicosanoids. Reprod. Fertil. Dev., 1990; 2:467–476.

Reilly W., et al. Phallic urethra in female pseudohermaphroditism. J. Dis. Child, 1958; 95:9–17.

Reins M. S., Barbieri R. L., Friedman A. J. Progesterone: a critical role in the pathogenesis of uterine myomas. Am. J. Obstet. Gynecol., 1995; 172 (1 Pt 1):14–18.

Reins M. S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect, 2000; 108 Suppl 5:791–793.

Reiss S., McNally R. J. The expectancy model of fear. In: Reiss, S.; Bootzin, R.R., editors. Theoretical issues in behavior therapy. New York: Academic Press, 1985; 107–122.

Ren D. J., et al. A sperm ion channel required for sperm motility and male fertility. Nature, 2001; 413:603–609.

Resseguie L. J., et al. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936–1974. Fertil. Steril., 1985; 43:514–519.

Revesz C., Chappel C., Gaudry R. Masculinization of female fetuses in the rat by progestational compounds. Endocrinology, 1960; 66:140–143.

Reznikoff-Etievant M. F., et al. Low vitamin B12 level as risk factor for very early recurrent abortion. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002; 104:156–159.

Rhodes M. E., Frye C. A. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cognitive, Affective, & Behavioral Neuroscience, 2001; 1:287–296.

Richer J. K., et al. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. Journal of Biological Chemistry, 2002; 277:5209–5218.

Riddick D. H., et al. De novo synthesis of prolactin by human decidua. Life Sci., 1978; 23:1913–1921.

Riss P. A., Radivojevic K., Bieglmayer C. Serum progesterone and human chorionic gonadotropin in very early pregnancy: implications for clinical management. Eur. J. Obstet. Gynecol. Reprod. Biol., 1989; 32:71–77.

Rivier C., Rivest S. Effect of stress on the activity of the hypothalamicpituitary-gonadal axis peripheral and central mechanisms. Biol. Reprod., 1991; 45:523–532.

Robiero L. S., Izquierdo L. Effect of progesterone on the cleavage rate of mouse embryos in vitro. J. Reprod. Fert., 1976; 46:475–476.

Robker R. L., et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. USA, 2000; 97:4689–4694.

Roblero L. S., Garavagno A. C. Effect of oestradiol-17β and progesterone on oviductal transport and early development of mouse embryos. J. Reprod. Fert., 1979; 57:91–95.

Roblero L. S. Effect of progesterone in vivo upon the rate of cleavage of mouse embryos. Reprod. Fert., 1973; 35:153–155.

Rock J. A., et al. Fetal malformations following progesterone therapy during pregnancy: a preliminary report. Fertil. Steril., 1985; 44:17–19.

Rogers P. A. Endometrial vasculature in Norplant users. Hum. Reprod., 1996; 11 (Suppl 2):45–50.

Rojas-Marcos P. M., David R., Kohn B. Hormonal effects in infants conceived by assisted reproductive technology. Pediatrics, 2005; 116:190–194.

Roman E. A., Alberman E., Pharoah P. O. Pregnancy order and fetal loss. BMJ, 1980; 280:715.

Romero R., et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am. J. Obstet. Gynecol., 2012; 206:124.e1–19.

Rose D. P., et al. High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am. J. Clin. Nutr., 1991; 54:520–525.

Ross, et al. Is it possible to estimate the minimal clinically important treatment effect needed to change practice in preterm birth prevention? Results of an obstetrician survey used to support the design of a trial. BMC Medical Research Methodology, 2012; 12:31.

Rossouw J. E., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 2002; 288:321–333.

Rouse D. J., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N. Engl. J. Med., 2007; 357:454–61.

Rubinow D. R., et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. AJOG, 1988; 158:5–11.

Runic R., et al. Effects of Norplant on endometrial tissue factor expression and blood vessel structure. J. Clin. Endocrinol. Metab., 2000; 85:3853–3859.